IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Goodwill (2022 - 2024)

Updated

IRulya Therapeutics (IRLA) recorded Goodwill of $17.25 million in Q1 2024, down 2.2% from the prior quarter.

Analysis

IRulya Therapeutics (IRLA) Goodwill (2022 - 2024) Analysis & Trends

At the end of FY2023, IRulya Therapeutics reported Goodwill of $17.63 million.

  • The Q1 2024 figure is the lowest quarterly Goodwill since Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 IRulya Therapeutics 207.35 Mn 91.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 17.25 Mn
Dec 31, 2023 17.63 Mn
Jun 30, 2022 825,000.00
API Access

IRulya Therapeutics Goodwill API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill&ticker=IRLA&period=max&api_key=YOUR_API_KEY